C12N 2760/20161
Methods of inactivation or attenuation
C12N2760/20161 (Methods of inactivation or attenuation) appears on 14 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 20
- Assignees
- 17
- Inventors
- 24
- Latest grant
- 28 Apr 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 1 | 2 |
| 2004 | 3 | 2 |
| 2005 | 1 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 1 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof28 Apr 2020US 10,632,188 B2Universal Stabilization Technologies, Inc.
- Systems and methods for virus propagation in cell cultures for vaccine manufacture1 May 2018US 9,957,485 B2Inventprise, LLC
- Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof29 Aug 2017US 9,744,227 B2Universal Stabilization Technologies, Inc.
- Rabies virus vector systems and compositions and methods thereof21 Oct 2014US 8,865,461 B2The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
- Rabies virus vector systems and compositions and methods thereof4 Jan 2011US 7,863,041 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
- A therapeutic against crimean-congo hemorrhagic fever virus6 Feb 2025US 2025/0041398 A1Thomas Jefferson University
- Compositions and methods for tracing cell networks9 May 2024US 2024/0151709 A1The Brigham and Women S Hospital, Inc.
- Coronavirus vaccine compositions and methods of use22 Jun 2023US 2023/0190919 A1Thomas Jefferson University
- Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals & methods for formulation thereof10 May 2018US 2018/0125966 A1Universal Stabilization Technologies, Inc.
- Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals & methods for formulation thereof30 Mar 2017US 2017/0087243 A9Universal Stabilization Technologies, Inc.
Most cited
By later US patents
- Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof9US 9,744,227 B2Universal Stabilization Technologies, Inc. · 2017
- Systems and methods for virus propagation in cell cultures for vaccine manufacture8US 9,957,485 B2Inventprise, LLC · 2018
- Stable, attenuated rabies virus mutants and live vaccines thereof6US 6,719,981 B1Akzo Nobel N. V. · 2004
- Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof5US 6,777,220 B2Research Development Foundation · 2004
- Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife5US 7,074,413 B2Thomas Jefferson University · 2006